Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nigel Trudgill

Showing results (61-70 of 71) with videos related to

Pageof 8
Sort By:
Annals of Surgery|September 2, 2024
Prevalence and Risk Factors for Malignant Nodal Involvement in Early Esophago-Gastric Adenocarcinoma: Results From the Multicenter Retrospective Congress Study (endosCopic resectiON, esophaGectomy or Gastrectomy for Early Esophagogastric Cancers)Philip H Pucher, Saqib A Rahman, Pradeep Bhandari, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|October 15, 2025
Impact of staging investigations on nodal upstaging in early esophago-gastric adenocarcinoma: multicenter CONGRESS dataset analysisKirsty Cole, James A Gossage, Pradeep Bhandari, et al.
BJS Open|May 22, 2026
Interhospital variations in practice and technical outcomes for endoscopic resection of early oesophagogastric adenocarcinoma: multicentre CONGRESS data set analysisKirsty Cole, Pradeep Bhandari, James A Gossage, et al.
Alimentary Pharmacology & Therapeutics|March 3, 2023
Randomised, placebo-controlled trial and meta-analysis show benefit of ondansetron for irritable bowel syndrome with diarrhoea: The TRITON trialDavid Gunn, Rabia Topan, Lorna Barnard, et al.
Gut|October 30, 2013
British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagusRebecca C Fitzgerald, Massimiliano di Pietro, Krish Ragunath, et al.
Trials|August 21, 2019
Treatment of irritable bowel syndrome with diarrhoea using titrated ondansetron (TRITON): study protocol for a randomised controlled trialDavid Gunn, Ron Fried, Rabia Lalani, et al.
Alimentary Pharmacology & Therapeutics|March 5, 2022
Assessment of the role of the Edinburgh dysphagia score in referral triage in a national service evaluation of the urgent suspected upper gastrointestinal cancer pathwayUmair Kamran, Dominic King, Matthew Banks, et al.
The American Journal of Gastroenterology|April 15, 2015
BOB CAT: A Large-Scale Review and Delphi Consensus for Management of Barrett's Esophagus With No Dysplasia, Indefinite for, or Low-Grade DysplasiaCathy Bennett, Paul Moayyedi, Douglas A Corley, et al.
The American Journal of Gastroenterology|June 9, 2015
Addendum: BOB CAT: A Large-Scale Review and Delphi Consensus for Management of Barrett's Esophagus With No Dysplasia, Indefinite for, or Low-Grade DysplasiaCathy Bennett, Paul Moayyedi, Douglas A Corley, et al.
Gastroenterology|December 3, 2014
Polymorphisms near TBX5 and GDF7 are associated with increased risk for Barrett's esophagusClaire Palles, Laura Chegwidden, Xinzhong Li, et al.
Pageof 8

Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
Annals of Surgery|September 2, 2024
Prevalence and Risk Factors for Malignant Nodal Involvement in Early Esophago-Gastric Adenocarcinoma: Results From the Multicenter Retrospective Congress Study (endosCopic resectiON, esophaGectomy or Gastrectomy for Early Esophagogastric Cancers)Philip H Pucher, Saqib A Rahman, Pradeep Bhandari, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|October 15, 2025
Impact of staging investigations on nodal upstaging in early esophago-gastric adenocarcinoma: multicenter CONGRESS dataset analysisKirsty Cole, James A Gossage, Pradeep Bhandari, et al.
BJS Open|May 22, 2026
Interhospital variations in practice and technical outcomes for endoscopic resection of early oesophagogastric adenocarcinoma: multicentre CONGRESS data set analysisKirsty Cole, Pradeep Bhandari, James A Gossage, et al.
Alimentary Pharmacology & Therapeutics|March 3, 2023
Randomised, placebo-controlled trial and meta-analysis show benefit of ondansetron for irritable bowel syndrome with diarrhoea: The TRITON trialDavid Gunn, Rabia Topan, Lorna Barnard, et al.
Gut|October 30, 2013
British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagusRebecca C Fitzgerald, Massimiliano di Pietro, Krish Ragunath, et al.
Trials|August 21, 2019
Treatment of irritable bowel syndrome with diarrhoea using titrated ondansetron (TRITON): study protocol for a randomised controlled trialDavid Gunn, Ron Fried, Rabia Lalani, et al.
Alimentary Pharmacology & Therapeutics|March 5, 2022
Assessment of the role of the Edinburgh dysphagia score in referral triage in a national service evaluation of the urgent suspected upper gastrointestinal cancer pathwayUmair Kamran, Dominic King, Matthew Banks, et al.
The American Journal of Gastroenterology|April 15, 2015
BOB CAT: A Large-Scale Review and Delphi Consensus for Management of Barrett's Esophagus With No Dysplasia, Indefinite for, or Low-Grade DysplasiaCathy Bennett, Paul Moayyedi, Douglas A Corley, et al.
The American Journal of Gastroenterology|June 9, 2015
Addendum: BOB CAT: A Large-Scale Review and Delphi Consensus for Management of Barrett's Esophagus With No Dysplasia, Indefinite for, or Low-Grade DysplasiaCathy Bennett, Paul Moayyedi, Douglas A Corley, et al.
Gastroenterology|December 3, 2014
Polymorphisms near TBX5 and GDF7 are associated with increased risk for Barrett's esophagusClaire Palles, Laura Chegwidden, Xinzhong Li, et al.
Pageof 8